(Q40017793)

English

Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.

scientific article published on January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

based on heuristic

inferred from title

Toshiro Shirakawa

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Asako Okamoto

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Toshinori Bito

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Katsumi Shigemura

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Katsuyuki Hamada

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Akinobu Gotoh

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Masato Fujisawa

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Masato Kawabata

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

0 references

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

71

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

156-160

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Evaluation and follow-up strategies for superficial bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Prevention of bladder cancer: a review.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Non-steroidal anti-inflammatory drugs and bladder cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Cyclooxygenase-2: a target for the prevention and treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Many actions of cyclooxygenase-2 in cellular dynamics and in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Cinnamaldehyde reduces IL-1beta-induced cyclooxygenase-2 activity in rat cerebral microvascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Flavonoids differentially regulate IFN gamma-induced ICAM-1 expression in human keratinocytes: molecular mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Etodolac versus dexamethasone effect in reduction of postoperative symptoms following surgical endodontic treatment: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.061

7 January 2021

Identifiers

10.1016/J.UROLOGY.2007.09.061

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242386%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40017793&oldid=1523362338"